Australia markets closed

PharmAust Limited (PAA.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0860+0.0050 (+6.17%)
At close: 03:58PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 26.94M
Enterprise value 25.55M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.85
Price/book (mrq)3.20
Enterprise value/revenue 9.41
Enterprise value/EBITDA -18.90

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-6.52%
S&P500 52-week change 3-3.39%
52-week high 30.1200
52-week low 30.0650
50-day moving average 30.0836
200-day moving average 30.0932

Share statistics

Avg vol (3-month) 3173.31k
Avg vol (10-day) 3198.5k
Shares outstanding 5316.91M
Implied shares outstanding 6N/A
Float 8202.37M
% held by insiders 136.14%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 330 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin -48.14%
Operating margin (ttm)-46.39%

Management effectiveness

Return on assets (ttm)-9.38%
Return on equity (ttm)-19.54%

Income statement

Revenue (ttm)3.6M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-3.30%
Gross profit (ttm)3.43M
EBITDA -1.49M
Net income avi to common (ttm)-1.73M
Diluted EPS (ttm)-0.0060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.63M
Total cash per share (mrq)0.01
Total debt (mrq)1.24M
Total debt/equity (mrq)14.76
Current ratio (mrq)3.54
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-1.28M
Levered free cash flow (ttm)-853.37k